HomeInsightsResults

Poly Medicure Ltd Quarterly Result

Poly Medicure Ltd Quarterly Result

stocks purchased

₹ 1.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

6.3 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 22, 2024

Image

Poly Medicure Ltd

NSE: POLYMED

Net Profit

₹ 87.45

Last updated on: Nov 22, 2024

Key Highlights

  • The revenue of Poly Medicure Ltd for the Sep '24 is ₹ 446.86 crore as compare to the Jun '24 revenue of ₹ 402.13 crore. This represent the growth of 11.123263%.
  • The ebitda of Poly Medicure Ltd for the Sep '24 is ₹ 142.18 crore as compare to the Jun '24 ebitda of ₹ 121.27 crore. This represent the growth of 17.242514%.
  • The net profit of Poly Medicure Ltd for the Sep '24 is ₹ 87.45 crore as compare to the Jun '24 net profit of ₹ 74.04 crore. This represent the growth of 18.111826%.

Results Analysis

Market Price of Poly Medicure Ltd

1M

1Y

3Y

5Y

Monitoring Poly Medicure Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Nov 20242589.4
19 Nov 20242603.25
18 Nov 20242617.55
14 Nov 20242696.2
13 Nov 20242653.95
12 Nov 20242707.95
11 Nov 20242734.35
08 Nov 20242775.7
07 Nov 20242849.25
06 Nov 20242839.65

Historical Revenue of Poly Medicure Ltd

No data available

* All values are in crore

Historical EBITDA of Poly Medicure Ltd

No data available

* All values are in crore

Historical Net Profit of Poly Medicure Ltd

No data available

* All values are in crore

Poly Medicure Ltd News Hub

News

Poly Medicure corrects on profit selling

The stock soared 23.16% in the past three sessions, driven by strong Q2FY25 results announ...

Read more

04 Nov 202414:00

News

Poly Medicure Ltd leads losers in 'A' group

Voltamp Transformers Ltd, Force Motors Ltd, Vodafone Idea Ltd and PVR Inox Ltd are among t...

Read more

04 Nov 202415:00

News

Poly Medicure to announce Quarterly Result

Poly Medicure will hold a meeting of the Board of Directors of the Company on 28 October 2...

Read more

24 Oct 202418:22

News

Volumes soar at Poly Medicure Ltd counter

Aptus Value Housing Finance India Ltd, J K Cements Ltd, Raymond Ltd, KSB Ltd are among the...

Read more

14 Oct 202414:30

News

Poly Medicure Ltd leads losers in 'A' group

K E C International Ltd, TCI Express Ltd, Finolex Industries Ltd and Kalpataru Projects In...

Read more

20 Sep 202415:00

News

Poly Medicure schedules AGM

Poly Medicure announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

13 Sep 202411:37

Document

Annual Reports

Annual Report 2023

dropdown
download

Credit Ratings

Credit Report 2023

dropdown
download

Concalls

July 2024

TranscriptPPT

Feb 2024

Transcript

Nov 2023

Transcript

Aug 2023

Transcript

May 2023

PPT

Feb 2023

Transcript

Nov 2022

Transcript

Aug 2022

Transcript

Feb 2022

Transcript

Nov 2021

Transcript

July 2021

Transcript

Feb 2021

PPT

FAQ's For Poly Medicure Ltd Quarterly Result

What is the EPS of Poly Medicure Ltd stock?

The Earnings Per Share (EPS) of Poly Medicure Ltd is 29.1. An EPS is the amount of net income attributed to each share of a common stock.

How is Poly Medicure Ltd EPS calculated?

The EPS of Poly Medicure Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Poly Medicure Ltd report its EPS?

Poly Medicure Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Poly Medicure Ltd EPS?

Factors that influence the EPS of Poly Medicure Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Poly Medicure Ltd EPS growth indicate future performance?

Yes, consistent growth in Poly Medicure Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*